Fontsere´et al. [1] recently questioned the value of the Cockcroft-Gault (CG) formula and the MDRD equation for the long-term monitoring of glomerular filtration rate (GFR) in type 2 diabetic patients. As also reported by Rossing et al. [2] , they found that these equations underestimate the GFR decline; however, they concluded that the MDRD prediction could be used in their most advanced patients (CKD stages 2 and 3; baseline isotopic GFR: 71.2 AE 13.9 ml/ min/1.73 m 2 ). We tested whether the prediction equations can also be used in diabetic patients with more advanced renal impairment.
We have prospectively followed-up for 2 years 50 diabetic subjects (31, type 2) with impaired renal function (K/DOQI stages 3-5). Their GFR was determined by 51Cr-EDTA clearance, and compared to the CG and MDRD-predicted values by paired t-tests. The subjects were defined as 'progressors' if their GFR decline was higher than the mean of the studied group.
The mean initial GFR was 37.9 AE 21.7 ml/min/1.73 m 2 , similar to the MDRD (38.1 AE 15.9), whereas the CG overestimated GFR (42.4 AE 18.0; P < 0.05). Five subjects died during the follow-up. Their GFR (38.6 AE 21.8) did not differ from the others, but was overestimated by the CG (55.6 AE 12.0; P < 0.05) and the MDRD (44.1 AE 12.1; NS). Twelve subjects started haemodialysis. Their GFR (17.7 AE 8.9) was lower than the others (P < 0.0001), and was overestimated by the CG (26.4 AE 9.5; P < 0.0001) and the MDRD (22.3 AE 11.6; P < 0.05). Thirty-three subjects had a second GFR measurement 2 years later. Their GFR declined by À(7.7 AE 18.0) ml/min/1.73 m 2 [À(14 AE 37)%], from 45.1 AE 20.6 to 37.3 AE 21.6 (P < 0.05). The assessment of GFR decline by the CG and the MDRD is shown in Table 1 .
In accordance with Fontsere´ [1] and Rossing's [2] findings, we found that the GFR decline was underestimated by the predictive equations. The prediction was, however, correlated to the measured loss of renal function, and the underestimation was moderate: most of the subjects were well-classified as progressors or non-progressors according to their predicted GFR, especially with the MDRD. Despite its limitations, we think that the MDRD prediction is an acceptable alternative when the direct measurement of GFR cannot be performed in renally insufficient diabetic patients [3] . Reply Sir, In agreement with your recent study 'Prediction of glomerular filtration rate decline in diabetic subjects with impaired renal function' and those of Rossing et al. [1] , We believe the main interest in the use of the MDRD equation lies in the ambulatory monitoring of the decline of glomerular filtration in type 2 diabetic patients in chronic kidney disease stages 2 and 3 [2] . However, on the basis of our recent study [3] , we would like to emphasize the existence of significant biases in the application of these formulae in advanced stages of renal disease and in extreme situations of nutritional status and age. Despite the currently recommended clinical guidelines derived from large original epidemiological studies, one of the main limitations in the application of these formulae is the personalized estimation of renal function in each patient. Thus, to conclude, I believe the predictive equations to be useful tools for determining the degree of severity of kidney failure, particularly in epidemiologic studies, although they should be applied with a certain flexibility and for each individual patient when making important decisions such as initiating renal replacement treatment or prescribing potentially nephrotoxic drugs. 
